au.\*:("TEN CATE, H")
Results 1 to 25 of 75
Selection :
Disseminated intravascular coagulationLEVI, M; TEN CATE, H.The New England journal of medicine. 1999, Vol 341, Num 8, pp 586-592, issn 0028-4793Article
Applying abstraction and formal specification in numerical software designTEN CATE, H. H.Computers & mathematics with applications (1987). 1995, Vol 29, Num 12, pp 81-102, issn 0898-1221Article
QUANTITATIVE CHROMOGENIC ENDOTOXIN DETERMINATION IN CEREBROSPINAL FLUIDTHOMAS LLM; TEN CATE H; STURK A et al.1983; CLINICA CHIMICA ACTA; ISSN 0009-8981; NLD; DA. 1983; VOL. 127; NO 1; PP. 137-139; BIBL. 9 REF.Article
The association of disseminated intravascular coagulation with specific diseasesKRAMER, J; OTTEN, H. M; LEVI, M et al.Réanimation (Paris. 2001). 2002, Vol 11, Num 8, pp 575-583, issn 1624-0693, 9 p.Article
Low molecular weight heparin(oid)s : Clinical investigations and practical recommendationsNURMOHAMED, M. T; TEN CATE, H; TEN CATE, J. W et al.Drugs (Basel). 1997, Vol 53, Num 5, pp 736-751, issn 0012-6667Article
The role of factor XI in coagulation : A matter of revisionMINNEMA, M. C; TEN CATE, H; HACK, C. E et al.Seminars in thrombosis and hemostasis. 1999, Vol 25, Num 4, pp 419-428, issn 0094-6176Article
Thrombin-mediated activation of endogenous factor XI in plasma in the presence of physiological glycosaminoglycans occurs only with high concentrations of thrombinWUILLEMIN, W. A; MERTENS, K; TEN CATE, H et al.British journal of haematology. 1996, Vol 92, Num 2, pp 466-472, issn 0007-1048Article
Pathogenesis of disseminated intravascular coagulation in sepsisLEVI, M; TEN CATE, H; VAN DER POLL, T et al.JAMA, the journal of the American Medical Association. 1993, Vol 270, Num 8, pp 975-979, issn 0098-7484Article
Disseminated intravascular coagulation : Clinical spectrum and established as well as new diagnostic approachesMÜLLER-BERGHAUS, G; TEN CATE, H; LEVI, M et al.Thrombosis and haemostasis. 1999, Vol 82, Num 2, pp 706-712, issn 0340-6245Article
Clinical manifestations and diagnosis of DICTEN CATE, H.Sepsis (Boston). 1999, Vol 3, Num 2, pp 147-151, issn 1385-0229Article
Clinical applications of new antithrombotic agentsBEIJERING, R. J. R; TEN CATE, H; TEN CATE, J. W et al.Annals of hematology (Print). 1996, Vol 72, Num 4, pp 177-183, issn 0939-5555Article
The pathophysiology of disseminated intravascular coagulationTEN CATE, H; TIMMERMAN, J. J; LEVI, M et al.Thrombosis and haemostasis. 1999, Vol 82, Num 2, pp 713-717, issn 0340-6245Article
Clinical studies with low-molecular-weight heparin (oid)s: an interim analysisTEN CATE, H; HENNY, C. P; TEN CATE, J. W et al.American journal of hematology. 1988, Vol 27, Num 2, pp 146-153, issn 0361-8609Article
The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemiaLEVI, M; VAN DER POLL, T; TEN CATE, H et al.European journal of clinical investigation. 1997, Vol 27, Num 1, pp 3-9, issn 0014-2972Article
Disseminated intravascular coagulationLEVI, M; DE JONGE, E; VAN DER POLL, T et al.Thrombosis and haemostasis. 1999, Vol 82, Num 2, pp 695-705, issn 0340-6245Article
What role do coagulation disorders play in the pathogenesis of leptospirosis?WAGENAAR, J. F. P; GORIS, M. G. A; SAKUNDARNO, M. S et al.TM & IH. Tropical medicine & international health. 2007, Vol 12, Num 1, pp 111-122, issn 1360-2276, 12 p.Article
Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal fab fragment against factor VII/VIIaBIEMOND, B. J; LEVI, M; TEN CATE, H et al.Thrombosis and haemostasis. 1995, Vol 73, Num 2, pp 223-230, issn 0340-6245Article
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzeesLEVI, M; TEN CATE, H; BAUER, K. A et al.The Journal of clinical investigation. 1994, Vol 93, Num 1, pp 114-120, issn 0021-9738Article
Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzeesKUIPERS, B; VAN DER POLL, T; LEVI, M et al.The Journal of immunology (1950). 1994, Vol 152, Num 5, pp 2438-2446, issn 0022-1767Article
Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemiaVAN DER POLL, T; JANSEN, J; VAN LEENEN, D et al.The Journal of infectious diseases. 1993, Vol 168, Num 4, pp 955-960, issn 0022-1899Article
Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivoBAUER, K. A; MANNUCCI, P. M; GRINGERI, A et al.Blood. 1992, Vol 79, Num 8, pp 2039-2047, issn 0006-4971Article
Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoidHOEK, J. A; NURMOHAMED, M. T; HAMELYNCK, K. J et al.Thrombosis and haemostasis. 1992, Vol 67, Num 1, pp 28-32, issn 0340-6245Article
Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humansBAUER, K. A; TEN CATE, H; BARZEGAR, S et al.Blood. 1989, Vol 74, Num 1, pp 165-172, issn 0006-4971Article
Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic diseaseTEN CATE, H; HENNY, C. P; BÜLLER, H. R et al.Annals of neurology. 1984, Vol 15, Num 3, pp 268-270, issn 0364-5134Article
Activation of clotting factors XI and IX in patients with acute myocardial infarctionMINNEMA, M. C; PETERS, R. J. G; DE WINTER, R et al.Arteriosclerosis, thrombosis, and vascular biology. 2000, Vol 20, Num 11, pp 2489-2493, issn 1079-5642Article